Cott (TSE:PRM) Stock Rating Lowered by Raymond James

Raymond James cut shares of Cott (TSE:PRMFree Report) from a moderate buy rating to a hold rating in a research report report published on Wednesday morning, Zacks.com reports.

Cott Stock Up 0.6 %

PRM opened at C$14.23 on Wednesday. Cott has a twelve month low of C$13.20 and a twelve month high of C$14.97.

Cott Company Profile

(Get Free Report)

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Featured Articles

Receive News & Ratings for Cott Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cott and related companies with MarketBeat.com's FREE daily email newsletter.